All Updates

All Updates

icon
Filter
Partnerships
Evotec enters research collaboration with Pfizer to develop treatments for metabolic and infectious diseases
Precision Medicine
Jul 10, 2024
This week:
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Cohesity enhances Gaia, its AI assistant, with visual data exploration and expanded data sources
Data Infrastructure & Analytics
Oct 22, 2024
Product updates
Finzly launches FedNow service through BankOS platform in AWS marketplace
FinTech Infrastructure
Oct 22, 2024
Product updates
Runway launches Act-One for AI facial expression motion capture
Generative AI Applications
Oct 22, 2024
Product updates
Ideogram launches Canvas for image manipulation and generation
Generative AI Applications
Oct 22, 2024
Partnerships
UiPath partners with Inflection AI to integrate AI solutions for enterprises
Generative AI Applications
Oct 22, 2024
Precision Medicine

Precision Medicine

Jul 10, 2024

Evotec enters research collaboration with Pfizer to develop treatments for metabolic and infectious diseases

Partnerships

  • Evotec has entered a multi-year research collaboration and option and license agreement with Pfizer, aimed at discovering novel therapies for metabolic and infectious diseases.

  • The research will take place at Evotec's facilities in France, including Campus Curie, a state-of-the-art research site with capabilities including high throughput screening, in vitro and in vivo biology, proteomics, and metabolomics. The research will be supported by funding from Pfizer, and Evotec will also be eligible for milestone and royalty payments.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.